Suture-Mediated Delivery System Reduces the Incidence of Uterine Scarring Through the TGF-β Pathway
Source abstract
Abstract
In recent years, factors such as the postponement of childbearing and the relaxation of the childbearing policy have led to an increase in the proportion of cesarean sections and other intrauterine surgeries among pregnant women, further increasing the incidence of uterine scars. Currently, there is a lack of effective clinical treatment methods for uterine scars. In this study, a suture loaded with gene medicine was designed for the repair of uterine scars. Specifically, the non-viral vector Lipo8000 was first used to form a complex solution with the plasmid TGF-β3. Then, it was mixed and adsorbed with the surgical sutures pretreated with recombinant human type III collagen (RhCol III). In vitro experiments confirmed that RhCol III and the plasmid were successfully loaded onto the sutures and could be released and expressed. In vivo experiments were carried out using a rat model simulating uterine scars. The section results showed that compared with the scar model group, the expression level of TGF-β3 in the RhCol III+TGF-β3 group increased by 39%, the expression level of TGF-β1 decreased by 62.8%, and the fibrosis rate decreased by 16.8%, which has a positive effect on the prevention of uterine scars. This study integrates the therapeutic medicine into the sutures, ensuring that the medicine can come into contact with the wound site after suturing. Moreover, RhCol III and the gene medicine work synergistically to promote the repair of uterine wounds.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Surgical Sutures and Adhesives · Pregnancy-related medical research · Pelvic and Acetabular Injuries
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmacy, Changzhou University, Changzhou 213164, China
Changzhou Maternity and Child Health Care Hospital, Changzhou 213003, China
Funding
Jiangsu Province College Student Innovation · Entrepreneurship Training Program Project · Changzhou Famous Traditional Chinese Medicine Physicians Mentorship Program CWTCM [2024]
References (56)
Show source-provided references
1. Cesarean scar defect: Far from understood10.1016/j.fertnstert.2021.06.006 ↗
2. Trends and projections of caesarean section rates: Global and regional estimates10.1136/bmjgh-2021-005671 ↗
3. No Pain Labor & Delivery: A Global Health Initiative’s Impact on Clinical Outcomes in China10.1213/ANE.0000000000001328 ↗
4. Evaluation of Cesarean Rates for Term, Singleton, Live Vertex Deliveries in China in 2020 Among Women With No Prior Cesarean Delivery10.1001/jamanetworkopen.2023.4521 ↗
5. Cesarean scar defects: Management of an iatrogenic pathology whose prevalence has dramatically increased10.1016/j.fertnstert.2020.01.037 ↗
6. Application of ultrasonography in the diagnosis and treatment of cesarean Check for scar pregnancy10.1016/j.cca.2018.08.012 ↗
7. Hysteroscopic treatment of the cesarean-induced isthmocele in restoring infertility10.1097/GCO.0b013e3283521202 ↗
8. Surgical Management of Cesarean Scar Defect: The Hysteroscopic-Assisted Robotic Single-Site Technique10.1016/j.jmig.2019.06.007 ↗
9. Molecular mechanisms of uterine incision healing and scar formation10.1186/s40001-023-01485-w ↗
10. Tsuji, S., Nobuta, Y., Hanada, T., Takebayashi, A., Inatomi, A., Takahashi, A., Amano, T., and Murakami, T. (2023). Prevalence, definition, and etiology of cesarean scar defect and treatment of cesarean scar disorder: A narrative review. Reprod. Med. Biol., 22.10.1002/rmb2.12532 ↗
11. Surgical repair of a cesarean scar defect using a vaginal approach10.1016/j.fertnstert.2021.05.073 ↗
12. Cesarean scar pregnancy: A therapeutic dilemma10.1002/uog.23549 ↗
13. Curettage or operative hysteroscopy in the treatment of cesarean scar pregnancy10.1007/s00404-015-3730-1 ↗
14. Risk factors associated with failure of treatment for cesarean scar pregnancy10.1002/ijgo.12157 ↗
15. Cesarean Scar Pregnancies: A Systematic Review of Treatment Options10.1016/j.jmig.2017.05.019 ↗
16. Egorova, A., Maretina, M., Krylova, I., and Kiselev, A. (2024). Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis. Int. J. Mol. Sci., 25.10.3390/ijms25010013 ↗
17. Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction10.1016/j.placenta.2017.09.011 ↗
18. Targeting adenoviral vectors for enhanced gene therapy of uterine leiomyomas10.1093/humrep/det275 ↗
19. Treatment of cesarean scar pregnancy: Another chapter in the fertility preservation saga10.1016/j.fertnstert.2016.01.008 ↗
20. Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing10.1089/wound.2012.0406 ↗
21. Cesarean scar pregnancy: A systematic review of treatment studies10.1016/j.fertnstert.2015.12.130 ↗
22. Risk factors associated with the failure of initial treatment for cesarean scar pregnancy10.1002/ijgo.14761 ↗
23. Scar-free healing: From embryonic mechanisms to adult therapeutic intervention10.1098/rstb.2004.1475 ↗
24. Human umbilical cord mesenchymal stem cells improve uterine incision healing after cesarean delivery in rats by modulating the TGF-β/Smad signaling pathway10.1007/s00404-024-07381-w ↗
25. The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes10.1159/000524990 ↗
26. Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring10.1089/wound.2013.0429 ↗
27. Tissue Engineering and Regenerative Repair in Wound Healing10.1007/s10439-014-1010-z ↗
28. Pro-Regenerative Hydrogel Restores Scarless Skin during Cutaneous Wound Healing10.1002/adhm.201700659 ↗
29. Substances for regenerative wound healing during antler renewal stimulated scar-less restoration of rat cutaneous wounds10.1007/s00441-021-03505-9 ↗
30. Prophylactic administration of avotermin for improvement of skin scarring: Three double-blind, placebo-controlled, phase I/II studies10.1016/S0140-6736(09)60322-6 ↗
31. The Collagen Suprafamily: From Biosynthesis to Advanced Biomaterial Development10.1002/adma.201801651 ↗
32. Electrospun nanofibrous membranes of recombinant human collagen type III promote cutaneous wound healing10.1039/D3TB00438D ↗
33. Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen10.1093/jbcr/irae040 ↗
34. Diminished Type III Collagen Promotes Myofibroblast Differentiation and Increases Scar Deposition in Cutaneous Wound Healing10.1159/000322399 ↗
35. Collaborative Enhancement of Diabetic Wound Healing and Skin Regeneration by Recombinant Human Collagen Hydrogel and hADSCs10.1002/adhm.202401012 ↗
36. A regulatory perspective on recombinant collagen-based medical devices
37. Versatile dopamine-functionalized hyaluronic acid-recombinant human collagen hydrogel promoting diabetic wound healing via inflammation control and vascularization tissue regeneration
38. Ethidium bromide interactions with DNA: An exploration of a classic DNA-ligand complex with unbiased molecular dynamics simulations10.1093/nar/gkab143 ↗
39. Shuai, Q.Z., Liang, Y.X., Xu, X.R., Halbiyat, Z., Wang, X.W., Cheng, J.W., Liu, J.L., Huang, T.J., Peng, Z.W., and Wang, L. (2023). Sodium alginate hydrogel integrated with type III collagen and mesenchymal stem cell to promote endometrium regeneration and fertility restoration. Int. J. Biol. Macromol., 253.10.1016/j.ijbiomac.2023.127314 ↗
40. Xu, L.J., Liu, Y.F., Tang, L.Z., Xiao, H., Yang, Z., and Wang, S.F. (2022). Preparation of Recombinant Human Collagen III Protein Hydrogels with Sustained Release of Extracellular Vesicles for Skin Wound Healing. Int. J. Mol. Sci., 23.10.3390/ijms23116289 ↗
41. Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III10.1021/acsami.4c09890 ↗
42. Transplantation of human amniotic epithelial cells promotes morphological and functional regeneration in a rat uterine scar model10.1186/s13287-021-02260-6 ↗
43. Minimally invasive delivery of human umbilical cord-derived mesenchymal stem cells by an injectable hydrogel via Diels-Alder click reaction for the treatment of intrauterine adhesions10.1016/j.actbio.2024.02.001 ↗
44. Zhang, W.Y., He, Y.X., Chu, Y., Zhai, Y.X., Qian, S., Wang, X.H., Jiang, P.J., Cui, P.F., Zhang, Y., and Wang, J.H. (2024). Amorphous curcumin-based hydrogels to reduce the incidence of post-surgical intrauterine adhesions. Regen. Biomater., 11.10.1093/rb/rbae043 ↗
45. Mechanisms of Regeneration and Fibrosis in the Endometrium10.1146/annurev-cellbio-011723-021442 ↗
46. Novel microarchitecture of human endometrial glands: Implications in endometrial regeneration and pathologies10.1093/humupd/dmab039 ↗
47. Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo10.1093/eurheartj/ehab027 ↗
48. Circulating CD31 reflects endothelial activity and is associated with a lower risk for cardiovascular complications10.1093/eurheartj/ehac544.3054 ↗
49. TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats
50. Geuens, T., Ruiter, F.A.A., Schumacher, A., Morgan, F.L.C., Rademakers, T., Wiersma, L.E., Van den Berg, C.W., Rabelink, T.J., Baker, M.B., and LaPointe, V.L.S. (2021). Thiol-ene cross-linked alginate hydrogel encapsulation modulates the extracellular matrix of kidney organoids by reducing abnormal type 1a1 collagen deposition. Biomaterials, 275.10.1016/j.biomaterials.2021.120976 ↗
51. Loss of HDAC3 results in nonreceptive endometrium and female infertility10.1126/scitranslmed.aaf7533 ↗
52. Densification of Type I Collagen Matrices as a Model for Cardiac Fibrosis10.1002/adhm.201700114 ↗
53. JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models10.1126/scitranslmed.abb3312 ↗
54. Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury10.1038/nm.4354 ↗
55. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: Clinical implications for lesional site-directed therapy10.1111/j.1365-2133.2010.10048.x ↗
56. TGF-β decreases type I collagen and scarring after labioplasty10.1177/154405910308200714 ↗